Kintara Therap Trials - LARVOL Sigma

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

dianhydrogalactitol (VAL-083) / Valent Tech

ChiCTR2000041279: A single-arm, multicenter, exploratory, post-marketing clinical study of evaluating desquaxel for injection in the second-line treatment of patients with extensive stage small cell lung cancer

Recruiting

Dianhydrodulcitol for Injection

Cancer Hospital Chinese Academy of Medical Sciences; Guangxi Zhongheng Innovation Pharmaceutical Research Co. LTD, Guangxi Zhongheng Innovation Pharmaceutical Research Co. LTD

Extensive stage Small Cell Lung Cance

GBM AGILE, NCT03970447 / 2020-002250-24: A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

	Jan 2030 - Dec 2030: Market entry for glioblastoma
	Oct 2023 - Dec 2023: Top-line data from GBM AGILE trial for glioblastoma

Recruiting

2/3

1030

Europe, Canada, US, RoW

Temozolomide, Temodar, Temodal, Temcad, Lomustine, CCNU, CeeNU, Gleostine, Regorafenib, Stivarga, BAY 73-4506, Radiation, Paxalisib, GDC-0084, VAL-083, Dianhydrogalactitol, VT1021, Troriluzole, BHV-4157, ADI-PEG 20, Pegargiminase

Global Coalition for Adaptive Research, Bayer, Kazia Therapeutics Limited, Kintara Therapeutics, Inc., Biohaven Pharmaceuticals, Inc., Vigeo Therapeutics, Inc., Polaris Group

Glioblastoma

06/26

06/28

NCT03050736: Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression

Active, not recruiting

RoW

VAL-083 (Dianhydrogalactitol)

Kintara Therapeutics, Inc., Sun Yat-sen University

Glioma, Glioblastoma, Glioblastoma Multiforme, GBM, Brain Cancer

11/21

12/23

NCT02717962: Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting

	Topline data in GBM patients who have an unmethylated promoter of the MGMT gene
	Sep 2021 - Sep 2021: Topline data in GBM patients who have an unmethylated promoter of the MGMT gene

Active, not recruiting

119

VAL-083, Dianhydrogalactitol

Kintara Therapeutics, Inc.

Glioma, Glioblastoma, Glioblastoma Multiforme, GBM, Brain Cancer

12/23

03/24

NCT03138629: Expanded Access to VAL-083

No Longer Available

N/A

VAL-083

Kintara Therapeutics, Inc.

Cancer

REM-001 therapy / Kintara Therap

KTI-21-01, NCT05374915: Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)

Recruiting

REM-001 photodynamic therapy

Kintara Therapeutics, Inc.

Cutaneous Breast Cancer

12/24



	Diseases Companies Products Productz Mechanisms of Action Sites